Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Wolters

Showing results (91-100 of 253) with videos related to

Pageof 26
Sort By:
European Journal of Pharmacology|April 22, 1993
The selective dopamine D1 receptor agonist, SKF 81297, stimulates motor behaviour of MPTP-lesioned monkeysR J Vermeulen, B Drukarch, M C Sahadat, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 18, 2003
[(123)I]beta-CIT SPECT is a useful method for monitoring dopaminergic degeneration in early stage Parkinson's diseaseA Winogrodzka, P Bergmans, J Booij, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 1, 1994
The dopamine D1 agonist SKF 81297 and the dopamine D2 agonist LY 171555 act synergistically to stimulate motor behavior of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned parkinsonian rhesus monkeysR J Vermeulen, B Drukarch, M C Sahadat, et al.
Annals of Neurology|February 1, 1995
Concentrations of amyloid beta protein in cerebrospinal fluid of patients with Alzheimer's diseaseW A van Gool, M A Kuiper, G J Walstra, et al.
Journal of the Neurological Sciences|July 1, 1987
Sneddon's syndrome. Case report and literature reviewR P Bruyn, J P van der Veen, A J Donker, et al.
Neuroscience Letters|December 19, 1988
A new device for the quantitative assessment of dopaminergic drug effects in unilateral MPTP-lesioned monkeysE C Wolters, J C Kebabian, M Guttman, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|November 22, 2001
[123I]FP-CIT SPECT is a useful method to monitor the rate of dopaminergic degeneration in early-stage Parkinson's diseaseA Winogrodzka, P Bergmans, J Booij, et al.
Nederlands Tijdschrift Voor Geneeskunde|April 11, 1992
[Parkinson disease, a simple diagnosis?]N P Verhoeff, E A van Royen, J D Speelman, et al.
Neurology|July 1, 1990
DGAVP (Org 5667) in early Alzheimer's disease patients: an international double-blind, placebo-controlled, multicenter trialE C Wolters, P Riekkinen, A Lowenthal, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 24, 2001
Loss of olfaction in de novo and treated Parkinson's disease: possible implications for early diagnosisG Tissingh, H W Berendse, P Bergmans, et al.
Pageof 26

Showing results (91-100 of 253) with videos related to

Sort By:
Pageof 26
European Journal of Pharmacology|April 22, 1993
The selective dopamine D1 receptor agonist, SKF 81297, stimulates motor behaviour of MPTP-lesioned monkeysR J Vermeulen, B Drukarch, M C Sahadat, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 18, 2003
[(123)I]beta-CIT SPECT is a useful method for monitoring dopaminergic degeneration in early stage Parkinson's diseaseA Winogrodzka, P Bergmans, J Booij, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 1, 1994
The dopamine D1 agonist SKF 81297 and the dopamine D2 agonist LY 171555 act synergistically to stimulate motor behavior of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned parkinsonian rhesus monkeysR J Vermeulen, B Drukarch, M C Sahadat, et al.
Annals of Neurology|February 1, 1995
Concentrations of amyloid beta protein in cerebrospinal fluid of patients with Alzheimer's diseaseW A van Gool, M A Kuiper, G J Walstra, et al.
Journal of the Neurological Sciences|July 1, 1987
Sneddon's syndrome. Case report and literature reviewR P Bruyn, J P van der Veen, A J Donker, et al.
Neuroscience Letters|December 19, 1988
A new device for the quantitative assessment of dopaminergic drug effects in unilateral MPTP-lesioned monkeysE C Wolters, J C Kebabian, M Guttman, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|November 22, 2001
[123I]FP-CIT SPECT is a useful method to monitor the rate of dopaminergic degeneration in early-stage Parkinson's diseaseA Winogrodzka, P Bergmans, J Booij, et al.
Nederlands Tijdschrift Voor Geneeskunde|April 11, 1992
[Parkinson disease, a simple diagnosis?]N P Verhoeff, E A van Royen, J D Speelman, et al.
Neurology|July 1, 1990
DGAVP (Org 5667) in early Alzheimer's disease patients: an international double-blind, placebo-controlled, multicenter trialE C Wolters, P Riekkinen, A Lowenthal, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 24, 2001
Loss of olfaction in de novo and treated Parkinson's disease: possible implications for early diagnosisG Tissingh, H W Berendse, P Bergmans, et al.
Pageof 26